LOGIN
Volume:9
Issue:8
Number:12
ISSN#:2564-2537
Meta-analysis
ACE Report #8389
Ifosfamide-based chemotherapy yields high survival rate for treatment of osteosarcoma
How to Cite
OrthoEvidence. Ifosfamide-based chemotherapy yields high survival rate for treatment of osteosarcoma. ACE Report. 2020;9(8):12. Available from: https://myorthoevidence.com/AceReport/Report/8389
Study Type:Meta analysis
OE Level Evidence:1
Journal Level of Evidence:N/A
Efficacy and safety of ifosfamide-based chemotherapy for osteosarcoma: a meta-analysis
Drug Des Devel Ther. 2015 Nov 4;9:5925-32Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Seven randomized controlled trials with 2,529 patients with histologically confirmed osteosarcoma were included in this meta-analysis. The purpose of this study was to compare the safety and efficacy of ifosfamide-based chemotherapy to a control group receiving chemotherapy without ifosfamide. The results displayed that ifosfamide-based chemotherapy had significantly higher event-free survival, ov...
To view the full report, start your 30-day free trial today
No credit card required
JOIN LOGIN Forgot Password?Not sure if you want to join OrthoEvidence?
Access this report without an Account.Success, an email containing a link to access this report has been sent to your inbox.
Explore some of our unlocked reports below!
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.
LEARN MOREFor Reprints and Permissions, click here
Please Login or Join to leave comments.